What Happened?
Shares of healthcare services company Agilon Health (NYSE: AGL) jumped 29.9% in the afternoon session after Bernstein upgraded the stock's rating from Hold to Buy with a price target of $8.5. The firm noted that new data on AGL drove increased confidence in its turnaround plans and cash position.
The shares closed the day at $5.36, up 26.1% from previous close.
Is now the time to buy agilon health? Access our full analysis report here, it’s free.
What The Market Is Telling Us
agilon health’s shares are extremely volatile and have had 80 moves greater than 5% over the last year. But moves this big are rare even for agilon health and indicate this news significantly impacted the market’s perception of the business.
agilon health is up 176% since the beginning of the year, but at $5.30 per share, it is still trading 29.5% below its 52-week high of $7.52 from July 2024. Investors who bought $1,000 worth of agilon health’s shares at the IPO in April 2021 would now be looking at an investment worth $170.96.
Today’s young investors won’t have read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next.
